Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985823%3A_____%2F13%3A00395552" target="_blank" >RIV/67985823:_____/13:00395552 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.lfs.2013.07.018" target="_blank" >http://dx.doi.org/10.1016/j.lfs.2013.07.018</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.lfs.2013.07.018" target="_blank" >10.1016/j.lfs.2013.07.018</a>

Result language
angličtina
Original language name
Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia
Original language description
This pharmacological study examined the involvement of opioid receptor subtypes in the cardioprotective effect of chronic continuous hypoxia in rats. The results suggest that the infarct size-limiting effect afforded by adaptation to hypoxia is mediatedby activation of peripheral delta-2 and mju opioid receptors by elevated levels of endogenous opioid peptides
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—

Project
<a href="/en/project/GAP303%2F12%2F1162" target="_blank" >GAP303/12/1162: Interaction between sustained forms of cardioprotection induced by adaptation to chronic hypoxia and regular exercise training.</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)